5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
BUY | BUY | BUY | BUY | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 0.89▲ | 0.89▲ | 0.89▲ | 0.87▲ | 0.84▲ |
MA10 | 0.87▲ | 0.87▲ | 0.87▲ | 0.84▲ | 0.94▼ |
MA20 | 0.87▲ | 0.86▲ | 0.86▲ | 0.82▲ | 1.06▼ |
MA50 | 0.85▲ | 0.84▲ | 0.83▲ | 0.96▼ | 0.95▼ |
MA100 | 0.82▲ | 0.82▲ | 0.82▲ | 1.04▼ | 1.32▼ |
MA200 | 0.82▲ | 0.89▲ | 0.94▼ | 0.94▼ | 7.46▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.002▲ | 0.002▲ | 0.002▲ | 0.020▲ | -0.034▼ |
RSI | 58.704▲ | 58.892▲ | 58.995▲ | 51.228▲ | 46.358▼ |
STOCH | 76.207 | 83.292▲ | 83.292▲ | 89.657▲ | 25.963 |
WILL %R | -10.857▲ | -10.857▲ | -10.857▲ | -9.659▲ | -65.755 |
CCI | 104.282▲ | 105.119▲ | 104.741▲ | 122.714▲ | -65.557 |
Wednesday, April 16, 2025 03:21 PM
US-based biopharmaceutical company Hoth Therapeutics has reported interim data from a Phase IIa trial of HT-001, a drug designed for treating pruritus associated with skin toxicities caused by ...
|
Tuesday, April 15, 2025 05:54 AM
(RTTNews) - Hoth Therapeutics, Inc.(HOTH ... views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. Founded in the late 1990s by Andrew Mariathasan in New York ...
|
Tuesday, April 15, 2025 01:20 AM
HT-001 was well tolerated, with no treatment-related serious adverse events reported. (PRNewsfoto/Hoth Therapeutics Inc.) EGFR inhibitors, widely used in oncology, are often associated with skin ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
01/05/25 | 0.90 | 0.90 | 0.85 | 0.893 | 75,800 |
30/04/25 | 0.85 | 0.91 | 0.827 | 0.899 | 118,400 |
29/04/25 | 0.8679 | 0.8679 | 0.851 | 0.851 | 77,313 |
28/04/25 | 0.856 | 0.87 | 0.831 | 0.852 | 100,000 |
25/04/25 | 0.866 | 0.866 | 0.826 | 0.856 | 77,400 |
24/04/25 | 0.849 | 0.869 | 0.811 | 0.859 | 118,100 |
23/04/25 | 0.799 | 0.8397 | 0.79 | 0.8321 | 143,186 |
22/04/25 | 0.7727 | 0.82 | 0.752 | 0.80 | 181,732 |
21/04/25 | 0.7969 | 0.7969 | 0.74 | 0.7715 | 129,487 |
17/04/25 | 0.78 | 0.841 | 0.763 | 0.788 | 557,500 |
|
|
||||
|
|
||||
|
|